" /> Crenigacestat - CISMeF





Preferred Label : Crenigacestat;

NCIt synonyms : Gamma-Secretase Inhibitor LY3039478; 4,4,4-Trifluoro-N-((S)-1-(((S)-5-(2-hydroxyethyl)-6-oxo-6,7-dihydro-5H-benzo[d]pyrido[2,3-b]azepin-7-yl)amino)-1-oxopropan-2-yl)butanamide;

NCIt definition : An orally available inhibitor of the integral membrane protein gamma-secretase (GS), with potential antineoplastic activity. Upon administration, crenigacestat binds to the GS protease complex, thereby blocking the proteolytic cleavage and release of the Notch intracellular domain (NICD), which would normally follow ligand binding to the extracellular domain of the Notch receptor. This prevents both the subsequent translocation of NICD to the nucleus to form a transcription factor complex and the expression of Notch-regulated genes. This results in the induction of apoptosis and the inhibition of growth in tumor cells that overexpress Notch. Overexpression of the Notch signaling pathway plays an important role in tumor cell proliferation and survival.;

UNII : 923X28214S;

InChIKey : YCBAQKQAINQRFW-UGSOOPFHSA-N;

CAS number : 1421438-81-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1421438-81-4 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : JSMD194; LY-3039478; BMS-986405; LY 3039478;

NCI Metathesaurus CUI : CL1406068;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.